USD 25597.94 million
Report ID:
SQMIG35H2075 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|Tables:
36
|Figures:
74
Microfluidic Immunoassay Market size was valued at USD 28718.33 Million in 2023 and is poised to grow from USD 32219.09 Million in 2024 to USD 80661.72 Million by 2032, growing at a CAGR of 12.19% during the forecast period (2025-2032).
The microfluidic immunoassay market is expanding quickly and has the potential to improve patient care in situations with limited resources. POC tests are carried out in hospitals, ambulatory care facilities, doctor's offices, or even at the patients' homes. The demographic shift and demand for cost-effective, high throughput diagnosis are driving the POC industry's rapid growth. However, a lot of the current POC devices require sample pre-treatment before testing, yield inconsistent results, and provide subpar quantitative, qualitative, or qualitative and semi-quantitative test results. This prompted the downsizing of POC devices and a growing emphasis on delivering precise and quantitative results. A lot of interest has been paid to microfluidic systems (lab-on-a-chip) as a platform for miniature immunodiagnostics. Small amounts of reagents and samples are consumed, and exact findings are delivered quickly, as two major benefits of LOC.
The Microfluidic Immunoassay market is growing due to the larger benefits offered by LOC over conventional measurable methods, the growing need for POC in low-resource settings, increased research efforts in the field of microfluidic technology, a high intake of venture capital financing for the development of LOC-based POC diagnostics, rapid decision making employing POC diagnostics technologies in emergency care, and the rising incidence and prevalence of chronic diseases integrated with aging population across the globe.
US Microfluidic Immunoassay Market is poised to grow at a sustainable CAGR for the next forecast year.
Global Market Size
USD 25597.94 million
Largest Segment
Non-LOC POC technology
Fastest Growth
Non-LOC POC technology
Growth Rate
12.19% CAGR
To get more reports on the above market click here to Buy The Report
Global Microfluidic Immunoassay Market is segmented based on the technology, application and region. Based on technology, the market is segmented into LOC POC technology and quantitative non-LOC POC technologies. Based on application, the market is segmented into Cardiac Biomarker Detection, Inflammatory Biomarker Detection, Other Biomarkers and Emerging Biomarkers. Based on Region it is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.
Microfluidic Immunoassay Market Analysis by Technology
Based on technology, the non-LOC POC technologies category has controlled the most portion of the microfluidic immunoassay market in 2021. The significant market share of this sector is related to the increased acceptance of these technologies for a variety of diagnostic applications over time. Furthermore, electrochemical detection and optical detection are subcategories of the POC lab-on-chip (LOC) technologies market. The market for LOC POC technology was dominated by the electrochemical detection segment. This is because Abbotts's i-STAT microfluidic platform, which is based on electrochemical sensing technology and currently dominates the market.
Microfluidic Immunoassay Market Analysis by Application
Based on application, the microfluidic immunoassay market for cardiac biomarker detection has accounted for the highest proportion in 2021. Due to the increasing prevalence of cardiovascular disorders, the abundance of LOC-based solutions for cardiac biomarkers, and the relatively higher acceptance of these devices among end users, the cardiac biomarker detection category has a sizable market share.
To get detailed analysis on other segments, Request For Free Sample Report
The market for microfluidic immunoassays was dominated by North America, which was followed by Europe, Asia-Pacific, Latin America, the Middle East, and Africa. However, the Asia Pacific region is anticipated to grow at the fastest CAGR during the forecast period. This is largely because of the region's economies' accelerated growth, improved healthcare infrastructure, increased accessibility to healthcare services, and innovative products. It is also because of the aging population's increased risk of infectious and noncommunicable diseases, rising disposable income, and ongoing investment and focus by major players in emerging Asian markets.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Microfluidic Immunoassay Market Drivers
Novel Technologies in the Market are Creating Fruitful Growth Opportunities
Microfluidic Immunoassay Market Restraints
Lack of Access in Developing Nations to Hinder Market Growth
Request Free Customization of this report to help us to meet your business objectives.
Global microfluidic immunoassay market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D.
Microfluidic Immunoassay Market Top Player's Company Profiles
Becton, Dickinson and Company
Cepheid Inc.
Danaher Corporation
Fluidigm Corporation
Illumina Inc.
Luminex Corporation
Merck Millipore
NanoString Technologies Inc.
PerkinElmer Inc.
QIAGEN N.V.
Randox Laboratories Ltd.
Roche Diagnostics
Siemens Healthineers AG
Thermo Fisher Scientific Inc.
Tosoh Corporation
Wako Pure Chemical Industries, Ltd.
Waters Corporation
Microfluidic Immunoassay Market Recent Developments
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected utilizing Primary Exploratory Research backed by the robust Secondary Desk research.
According to our microfluidic immunoassay market analysis, in terms of technology, the non-LOC POC technologies segment held a larger market share. Owing to high preference for diagnostic applications. And in terms of application, the cardiac biomarker detection segment contributes to the market growth due to increasing prevalence of cardiovascular disorders. The main market drivers for microfluidic immunoassay include rapid test results with high precision and cutting-edge microfluidic immunoassay technology. These aspects are anticipated to fuel global expansion over the forecast period. However, issues with test repeatability are one factor that is anticipated to impede market expansion throughout the course of the projection period.
Report Metric | Details |
---|---|
Market size value in 2023 | USD 25597.94 million |
Market size value in 2031 | USD 71897.42 million |
Growth Rate | 12.19% |
Forecast period | 2024-2031 |
Forecast Unit (Value) | USD Million |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
Historical Year | 2019 |
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
For the Microfluidic Immunoassay Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Microfluidic Immunoassay Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Microfluidic Immunoassay Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Microfluidic Immunoassay Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Microfluidic Immunoassay Market size was valued at USD 25597.94 million in 2019 and is poised to grow from USD 28718.33 million in 2023 to USD 71897.42 million by 2031, growing at a CAGR of 12.19% in the forecast period (2024-2031).
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35H2075
sales@skyquestt.com
USA +1 351-333-4748